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Random Genetic Drift Determines the Level of Mutant mtDNA in Human
Primary Oocytes
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Wemeasured the proportion of mutant mtDNA (mutation load) in 82 primary oocytes from a womanwho harbored
the A3243G mtDNA mutation. The frequency distribution of mutation load indicates that random drift is the
principal mechanism that determines the level of mutant mtDNA within individual oocytes.
Pathogenic mtDNA mutations are present in ∼1/8,000
members of the U.K. population (Chinnery et al. 2000a)
and often cause progressive disabling neurological dis-
ease (Leonard and Schapira 2000). These mutations are
often heteroplasmic, with a mixture of mutant and wild-
type mtDNA present within a single individual (Larsson
and Clayton 1995). For the most common point mu-
tations, the presence of a higher percentage of mutant
mtDNA (mutation load) is associated with a more severe
clinical phenotype (Chinnery et al. 1997; White et al.
1999b).
For reasons that are not well understood, mtDNA
deletions are rarely, if ever, transmitted from clinically
affected women to their offspring. By contrast, women
who harbor heteroplasmic mtDNA point mutations or
mtDNA duplications transmit a variable amount of mu-
tant mtDNA (Poulton et al. 1998). This creates a prob-
lem in the clinic, because it is difficult to predict the
outcome of pregnancy. As illustrated in figure 1, the same
mother may have offspring with a range of clinical fea-
tures, from a severely affected fetus that dies in utero to
a mildly affected child who survives well into adult life
(for other examples, see Ciafaloni et al. 1992; de Vries
et al. 1994; White et al. 1999b). For some mtDNA mu-
tations there is a relationship between mutation load in
the mother and the outcome of pregnancy (Chinnery et
al. 1998; White et al. 1999a), but very little is known
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about the mechanisms of transmission of heteroplasmic
mtDNA mutations in humans.
Heteroplasmic female mice transmit neutral hetero-
plasmic mtDNA polymorphisms to their offspring, and
the variation among the offspring is largely determined
by random genetic drift (Jenuth et al. 1996). It is thought
that a restriction in the number of mtDNA molecules
early in embryogensis (the mitochondrial “genetic bottle-
neck”) is behind this process (Poulton et al. 1998). Al-
though no mouse model transmits a pathogenic hetero-
plasmic mtDNA mutation, Inoue et al. (2000) recently
generated matrilineal pedigrees of mice with high levels
of a heteroplasmic mtDNA deletion. However, these
mice also harbor mtDNA duplications, and it has yet to
be determined whether the duplications or the deletions
themselves are transmitted in the female germline (Ja-
cobs 2000). Further studies of these mice will undoubt-
edly cast light on the mechanisms of inheritance of
mtDNA heteroplasmy, but it remains to be established
whether random drift is the principal mechanism behind
the varied transmission of heteroplasmy in human ped-
igrees with mtDNA disease.
Attempts to study the inheritance of mtDNA hetero-
plasmy in humans have been hampered by a number of
problems. Very few human pedigrees are large enough
to permit reliable calculations of the variance between
offspring. Ovarian hyperstimulation may yield many
oocytes; however, because they have been artificially se-
lected, their mutation load may not reflect the level of
the whole population of primary oocytes. In addition,
the variable segregation of mutant mtDNA among var-
ious tissues throughout embryonic development—and
changes in the level of mutant mtDNA in various tissues
throughout life—may confound any clear relationship
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Figure 1 Previously unpublished pedigree of a family from the
northeast of England, showing the clinical variation among the off-
spring of a woman who transmitted the heteroplasmic A3243G
mtDNA point mutation (MIM 540000). Individual I:2 had offspring
that died either in utero (individuals II:1, II:2, and II:4) or !2 h after
birth (individual II:3). In addition, individual I:2 had a severely affected
child with short stature and bilateral sensorineural deafness who de-
veloped a recurrent encephalopathy, strokelike episodes, seizures,
ataxia, diabetes mellitus, and a cardiomyopathy in early adult life
(individual II:6, now 31 years old); and she had offspring who remain
asymptomatic in adult life (individual II:5 [27 years old] and individual
II:7 [33 years old]). TM p trimester.
Figure 2 Frequency distribution for the percentage of the
A3243G mutation in 82 primary oocytes selected at random from an
unstained cryostat section of freshly frozen ovarian tissue. The pro-
portion of mutant mtDNA within the primary oocytes was 0%–45%
(mean 12.64%; median 8.18%).
between maternal mutation load and the level found in
the offspring themselves.
To advance our understanding of the transmission of
pathogenic heteroplasmic mtDNAmutations in humans,
we performed the first study of mutant mtDNA within
a large number of single primary oocytes from a woman
who harbored the most common inherited heteroplasmic
mtDNA mutation: A3243G. This mutation classically
presents with mitochondrial encephalomyopathy, lac-
tic acidosis, and strokelike episodes (MELAS) (MIM
540000) (Goto et al. 1990), but it may also cause dia-
betes, cardiomyopathy, sensorineural deafness, and oph-
thalmoplegia (Leonard and Schapira 2000). If the level
of mtDNA heteroplasmy in single oocytes were deter-
mined by random genetic drift, one would expect the
frequency distribution of oocyte mutation load to be
binomial (Poulton et al. 1998).
The patient was a 41-year-old mother of two sons
who was known to have the A3243Gmutation although
she had no features of mitochondrial disease. (This
woman is not part of the family shown in figure 1.) She
underwent a total abdominal hysterectomy and bilateral
salpingo-oophorectomy for endometriosis, and she gave
informed consent for collection of ovarian wedge sam-
ples. Samples were frozen in liquid nitrogen immediately
after resection, and 10-mm frozen sections were cut per-
pendicular to the serosal surface. The first section was
stained with hematoxylin and eosin (H&E), to allow
tissue orientation, and adjacent sections were dried in
air, without staining or fixation. Primary oocytes were
identified on the H&E section and then on the adja-
cent unstained sections, by phase-contrast microscopy.
Eighty-two individual primary oocytes were dissected
using a 10-mm glass micropipette. They were then lysed,
and the proportion of mutant mtDNA within each oo-
cyte was determined by last-cycle fluorescent PCR, as
described elsewhere (Chinnery et al. 2000b).
The level of the A3243G mutation was 18.11% in
her quadriceps and 7.24% in her leukocytes. The pro-
portion of mutant mtDNA within the primary oocytes
was 0%–45% (mean 12.64%). The shape of the fre-
quency distribution for oocyte mutation load corre-
sponded to a binomial distribution (fig. 2). The median
level (8.18%) fell within the 95% confidence limits for
the sample mean for the binomial distribution, indicat-
ing that the number of oocytes with mutation loads
greater than the mean was approximately equal to the
number with mutation loads less than the mean.
These findings indicate that, as in mice (Jenuth et al.
1996), the level of mutant mtDNA in human primary
oocytes is largely determined by random genetic drift.
The continuous distribution of mutation load shown in
figure 2 contrasts with the findings by Blok et al. (1997),
who showed highly skewed segregation of the T8993G
mutation in oocytes harvested from a woman after ovar-
ian follicular hyperstimulation. It is possible that the
extreme levels of heteroplasmy noted by Blok et al.
(1997) arose through the random sampling of only seven
oocytes. This is unlikely, because they did not detect
intermediate levels of heteroplasmy—each oocyte that
they collected contained either 100% wild-type or
195%mutant mtDNA. It is well recognized that the rate
of segregation of the T8993G/C mutations differs mark-
edly from that of most other heteroplasmic mtDNA
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point mutations (Poulton and Turnbull 2000). This is
reflected in the size of the pedigrees: T8993G/C families
are usually small, because of the extremely rapid seg-
regation of mutant mtDNA, leading, within one or two
generations (White et al. 1999a, 1999b), to fixation or
loss of the new mutation. Less-dramatic shifts in mu-
tation load are seen in larger pedigrees, which transmit
other mtDNA point mutations, including A3243G
(Chinnery et al. 2000c). Because the variation in het-
eroplasmy between the offspring of a woman is largely
generated before the primary-oocyte stage (Jenuth et al.
1996), the differences in segregation patterns seen in
pedigrees is reflected by the level of mutant mtDNAmea-
sured in the harvested oocytes reported by Blok et al.
(1997) and in the primary oocytes reported here.
The measurements that we made on primary oocytes
can be used to estimate the size of the mitochondrial
genetic bottleneck. Various authors have used the pop-
ulation-genetic-bottleneck model developed by Wright
(1969) to study the mitochondrial genetic bottleneck
(Howell et al. 1992; Jenuth et al. 1996; Poulton et al.
1998). This model assumes that a population of infinite
size is instantaneously restricted to a minimum bottle-
neck size (N) for a number of generations (g) before the
population instantaneously expands back to an infinite
size. Under these circumstances, the size and duration
of the bottleneck determine the variation in the geno-
types among the subsequent lineages. The size of the
bottleneck (measured in “segregating units”) can be cal-
culated—provided that the duration of the bottleneck is
known—according to the following equation:
g1( )Vp p 1 p 1 1 , (1)0 0 ( )[ ]N
where V is the variation between offspring, and p0 is the
initial allele frequency. In humans, g is generally taken
to be the 24 synchronous cell divisions needed to pro-
duce a full quota of 8.3 million primary oocytes from
a single progenitor cell (Baker 1963). An alternative ap-
proach is to assume that a single sampling event occurs
once during development (Bendall et al. 1996). This
greatly simplifies the calculation, which can be modeled
using equation (1), where g p 1 (Poulton et al. 1998).
We have applied both models to the primary-oocyte data
presented here, assuming that the mean level of the
A3243G mutation for the 82 oocytes corresponds to the
initial allele frequency, p0, ( ), and that V isp p .12640
the variance between the individual primary oocytes
( ). When equation (1) with gp 24 is used,Vp .014321
the estimated bottleneck size, as based on the primary-
oocyte data, is 173 segregating units; when the single-
sampling approach is used, the estimated bottleneck size
is 8 segregating units. These figures closely correspond
to values for human pedigrees reported elsewhere (How-
ell et al. 1992; Jenuth et al. 1996; Poulton et al. 1998),
but they must be interpreted with caution. The size of
the segregating unit is not known, and it may correspond
to a single mitochondrial genome or to groups of
mtDNA molecules arranged in clusters, possibly com-
partmentalized within nucleoids or discrete mitochon-
dria. Although these models do not tell us about the
precise biological mechanisms involved in the inheri-
tance of mtDNA heteroplasmy, the calculations are of
value in the comparison of data obtained from various
sources. The mutation-load variation among primary
oocytes of our patient is of the same order of magnitude
as that between blood samples drawn from members of
human pedigrees transmitting the same or other muta-
tions (Chinnery et al. 2000c).
It is of interest that the level in the blood of our pa-
tient’s 15-year-old son was 11.70%, a value that fell just
within the 59% confidence interval of the mutation-load
distribution of the oocytes. Although the relationship
between oocyte mutation load and the outcome of preg-
nancy remains to be determined, it is significant that 8
(9.8%) of the 82 oocytes collected from our patient con-
tained undetectable levels of mutant mtDNA. It is well
recognized that women with heteroplasmic mtDNA
point mutations may have unaffected offspring (fig. 1;
also see Ciafaloni et al. 1992; Hammans et al. 1993;
White et al. 1999b). On the basis of our observations,
it is likely that the patient whom we describe here had
a 1/10 chance of not transmitting the mtDNA mutation
to her offspring. This information could not be confi-
dently determined by measuring the proportion of mu-
tant mtDNA in tissue from any organ other than the
ovary. Further studies will cast light on the relationship
between the percentage of mutant mtDNA in oocytes
and that in other tissues. Alternatively, under certain
circumstances, an ovarian biopsy may yield information
with important implications for a prospective mother.
In conclusion, although we cannot be certain that all
the primary oocytes that we collected would necessarily
develop into mature oocytes, we have provided evidence
that the level of the A3243G mutation within human
primary oocytes is determined by random genetic drift.
It is possible that higher levels of the A3243G mutation
may skew this distribution, particularly if they exceed
the critical threshold (185%) of mutant mtDNA needed
to produce a biochemical defect in transmitochondrial
cybrids (Chomyn et al. 1991). However, data from a
large number of independent pedigrees suggest that this
is not likely to have a major effect on the overall trans-
mission pattern for this and other mutations (Chinnery
et al. 2000c). We suspect that random genetic drift is
the principal mechanism behind the transmission of all
pathogenic heteroplasmic mtDNA point mutations. It is
likely that differences in the segregation pattern and ge-
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netic threshold contribute to the specific inheritance pat-
terns of various mtDNA defects.
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